slno,preds
0,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Invasion**: The primary lung tumor is 6.3 cm in diameter and invades the visceral pleura and parietal pericardium, but not the chest wall or mediastinum. This corresponds to a T3 classification, as the tumor is larger than 5 cm and invades the visceral pleura.

2. **Lymph Node Involvement**: Metastatic carcinoma is present in 3 out of 10 regional lymph nodes. This corresponds to an N1 classification, indicating metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.

3. **Distant Metastasis**: The report indicates pMX, meaning that distant metastasis cannot be assessed from the provided specimen.

Based on the AJCC 6th Edition staging system for lung cancer:
- **Stage I**: T1-2, N0, M0
- **Stage II**: T1-2, N1, M0
- **Stage III**: T3, N0-1, M0 or T1-3, N2, M0
- **Stage IV**: Any T, Any N, M1

Given the classification of pT3 pN1 pMX, the cancer is at least Stage III, as Stage III includes T3 with N0-1 and no distant metastasis (M0 or MX).

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
1,"## Answer
To determine the AJCC stage of the cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and metastasis.

1. **Tumor Size and Invasion (T):** 
   - The report describes a ""moderately differentiated adenocarcinoma"" with a size of 1.1 cm.
   - The tumor is invasive of the ""overlying pleura,"" which indicates pleural invasion. This suggests at least a T2 classification because T1 tumors do not invade the pleura.

2. **Lymph Node Involvement (N):**
   - The report mentions a ""benign intrapulmonary lymph node, negative for carcinoma,"" indicating no lymph node involvement (N0).

3. **Distant Metastasis (M):**
   - The report states that the ""margin of resection"" and the ""segment of rib"" are negative for carcinoma, suggesting no distant metastasis (M0).

Based on the above information:
- The tumor is T2 due to pleural invasion.
- There is no lymph node involvement (N0).
- There is no distant metastasis (M0).

According to the AJCC staging system for lung cancer:
- T2, N0, M0 corresponds to Stage IB.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
2,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor (T) Size and Extent**: The tumor is described as a poorly differentiated squamous cell carcinoma with a maximal dimension of 27 mm. According to the TNM classification, a tumor size of 27 mm falls under T1 (specifically T1c, which is for tumors more than 20 mm but 30 mm or less).

2. **Lymph Nodes (N) Involvement**: The report indicates that there is a deposit of poorly differentiated carcinoma present within the hilar lymph node cortex. This indicates N1 involvement, as N1 refers to metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes.

3. **Metastasis (M)**: The report states ""MX,"" which means distant metastasis cannot be assessed. However, there is no mention of distant metastasis being present.

Based on the TNM classification provided (T1N1MX), we can determine the stage:

- **Stage I**: Typically involves T1 or T2 with N0 and M0.
- **Stage II**: Typically involves T1 or T2 with N1 and M0.
- **Stage III**: Typically involves T3 or T4 and/or N2 or N3 with M0.
- **Stage IV**: Involves any T, any N, and M1.

Given the classification T1N1MX, the cancer is at Stage II, as it involves T1 with N1 and no confirmed distant metastasis (M0 or MX).

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
3,"## Answer
The pathology report provides the following key information:

1. **Primary Tumor (T):** The report describes a Grade II-III squamous carcinoma of the lung, measuring 4.5 x 3.5 x 2.0 cm, involving the pleura and focally to the inked pleural margin. The tumor does not invade the bronchial or vascular margins, which are negative. The involvement of the pleura suggests at least a T2 classification, possibly T3 if it is considered to invade the pleura significantly.

2. **Regional Lymph Nodes (N):** All examined lymph nodes (levels 9, 10, 5, and 7) are negative for tumor involvement. This indicates N0 status, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, suggesting M0 status.

Based on the TNM classification:
- T2 or T3 (due to pleural involvement)
- N0 (no lymph node involvement)
- M0 (no distant metastasis)

For lung cancer, Stage I is typically T1-2, N0, M0. Stage II can be T2-3, N0, M0 or T1-2, N1, M0. Stage III involves N2 or T4, and Stage IV involves M1.

Given the tumor size and pleural involvement, but with no lymph node or distant metastasis, the cancer is likely Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
4,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Extent (T):** The tumor is described as an exophytic invasive squamous cell carcinoma with a size of 3.7 x 2.8 x 2.8 cm. The tumor extends to the bronchial margin, but additional margins are negative for tumor. This corresponds to a T2 classification, as the tumor is greater than 3 cm but less than 5 cm in greatest dimension and involves the main bronchus without involvement of the carina.

2. **Lymph Node Involvement (N):** There is metastasis to one out of ten peribronchial lymph nodes, which corresponds to N1 classification. N1 indicates metastasis to ipsilateral peribronchial and/or hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.

3. **Distant Metastasis (M):** The report indicates Mx, meaning distant metastasis cannot be assessed. However, there is no evidence of distant metastasis provided in the report.

Based on the TNM classification:
- T2
- N1
- M0 (assuming no distant metastasis as Mx is not definitive for presence)

According to the AJCC staging system for lung cancer, a T2 N1 M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
5,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size**: The tumor is 2.4 cm in size.
2. **Lymph Node Involvement**: 0 out of 7 lymph nodes are involved, indicating no regional lymph node metastasis.
3. **Distant Metastasis**: The report states pMX, meaning distant metastasis cannot be assessed.
4. **TNM Staging**: The report provides a TNM classification of pT1b, pN0, pMX.

Based on the AJCC (American Joint Committee on Cancer) staging system for lung cancer:
- **T1b**: Tumor size is more than 2 cm but 3 cm or less in greatest dimension.
- **N0**: No regional lymph node metastasis.
- **M0**: No distant metastasis (though pMX indicates it wasn't assessed, we assume no evidence of metastasis for staging purposes).

Given the TNM classification of pT1b, pN0, and assuming M0, the cancer would be classified as Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
6,"## Answer
The pathology report provides the following key information for staging the cancer according to the AJCC (American Joint Committee on Cancer) guidelines:

1. **Primary Tumor (pT):** The tumor is classified as pT2a. This indicates that the tumor is greater than 3 cm but less than 5 cm in greatest dimension, surrounded by lung or visceral pleura, without invasion in the main bronchus.

2. **Regional Lymph Nodes (pN):** The classification is pN0, meaning there is no regional lymph node metastasis. All examined lymph nodes are negative for tumor involvement.

3. **Distant Metastasis (pM):** The report states ""Not applicable,"" which typically implies that there is no evidence of distant metastasis (pM0).

Based on the AJCC staging system for lung cancer:
- **Stage I** is characterized by a tumor that is limited in size (T1 or T2a) and has no lymph node involvement (N0) and no distant metastasis (M0).
- **Stage II** involves larger tumors or limited lymph node involvement.
- **Stage III** involves more extensive lymph node involvement or larger tumors with local invasion.
- **Stage IV** involves distant metastasis.

Given the tumor size (pT2a), lack of lymph node involvement (pN0), and no distant metastasis (pM0), the cancer is classified as Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
7,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Location**: The tumor is a poorly differentiated squamous cell carcinoma measuring 45 mm in diameter. It is located in the left upper lobe of the lung and abuts the visceral pleura but does not invade it.

2. **Margins and Invasion**: The tumor is clear of the bronchial resection margin, and there is no lymphatic, vascular, or perineural invasion.

3. **Lymph Nodes**: The peribronchial lymph nodes, left hilar lymph node, and mediastinal lymph node are not involved by the tumor.

4. **Pathological Stage**: The report explicitly states the pathological stage as pT2a N0.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **T2a**: Tumor size is more than 3 cm but 5 cm or less, or the tumor involves the main bronchus without involvement of the carina, invades visceral pleura, or is associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.
- **N0**: No regional lymph node metastasis.

Based on the T2a N0 classification, the cancer is classified as Stage IB according to the AJCC 8th edition staging system for lung cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
8,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Location**: The squamous cell carcinoma forms a subpleural mass measuring 5 x 4.5 x 2.6 cm. It extends into but not through the pleura. The bronchial margin is negative for the tumor.

2. **Lymph Node Involvement**: Multiple intrapulmonary peribronchial lymph nodes and multiple superior and inferior mediastinal, as well as N1 lymph nodes, are negative for the tumor.

3. **Grade**: The tumor is Grade 3 (of 4).

Based on the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **T (Tumor size and extent)**: The tumor is greater than 4 cm but less than 5 cm, which corresponds to T2b. It extends into but not through the pleura, which does not change the T classification.

- **N (Regional lymph nodes)**: No regional lymph node metastasis is noted (N0).

- **M (Distant metastasis)**: There is no mention of distant metastasis (M0).

Given these findings, the cancer is classified as T2b N0 M0. According to the AJCC 8th edition staging system for lung cancer, this corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
9,"## Answer
The pathology report indicates the following key findings:

1. The primary tumor is a poorly differentiated squamous cell carcinoma located in the left upper lobe of the lung, with a greatest diameter of 3.2 cm. The tumor involves the visceral pleura but does not show vascular or perineural invasion. The bronchial margin is free of tumor.

2. The lymph node status is reported as benign for all examined nodes, with no metastatic nodes identified (0/8 peribronchial nodes, and other mediastinal nodes are also benign).

3. There is no mention of distant metastasis.

Based on the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- T2a: Tumor size is greater than 3 cm but 5 cm or less, or involves the visceral pleura.
- N0: No regional lymph node metastasis.
- M0: No distant metastasis.

The combination of T2a, N0, and M0 corresponds to Stage IB in the AJCC staging system for non-small cell lung cancer (NSCLC).

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
10,"## Answer
The pathology report provides the following key information:

1. **Primary Tumor (pT):** The tumor is classified as pT1b. According to the AJCC staging system, pT1b indicates a tumor size greater than 1 cm but 2 cm or less in greatest dimension.

2. **Regional Lymph Nodes (pN):** The report states pN0, meaning there is no regional lymph node metastasis. All examined lymph nodes, including hilar and peribronchial, are negative for tumor involvement.

3. **Distant Metastasis (pM):** The report mentions ""Distant metastasis (pM): Not applicable,"" which implies there is no evidence of distant metastasis.

Based on the AJCC staging criteria for lung cancer:
- Stage I is characterized by a small tumor (T1) with no regional lymph node involvement (N0) and no distant metastasis (M0).
- Stage II involves larger tumors or limited lymph node involvement.
- Stage III involves more extensive lymph node involvement or larger tumors with certain local extensions.
- Stage IV involves distant metastasis.

Given the tumor size (pT1b), absence of lymph node involvement (pN0), and no distant metastasis (pM0), the cancer is classified as Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
11,"## Answer
The pathology report provides the following key information for staging:

1. **T Stage (Tumor size and extent):** The report indicates a T4 stage. This is due to the presence of two foci of moderately differentiated squamous cell carcinoma, with the largest being 4.5 cm in diameter, and associated with visceral pleural and angiolymphatic invasion. T4 indicates a tumor of any size that invades the mediastinum, heart, great vessels, trachea, esophagus, vertebral body, or carina, or separate tumor nodules in a different ipsilateral lobe, or tumor with malignant pleural effusion.

2. **N Stage (Lymph node involvement):** The report indicates N1 stage, as there is metastatic squamous cell carcinoma present in one of twelve N1 lymph nodes. N1 indicates metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.

3. **M Stage (Distant metastasis):** The report indicates Mx, meaning that the presence of distant metastasis cannot be assessed. However, the T4 classification and N1 involvement are sufficient to determine the stage without confirmed distant metastasis.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer, a T4N1Mx classification corresponds to Stage III. Stage III is characterized by locally advanced disease, which includes large tumors that invade nearby structures or have spread to nearby lymph nodes but not to distant sites.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
12,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size and Local Invasion (T):** 
   - The report describes a squamous cell carcinoma forming a mass of 2.3 x 2 x 1.8 cm in the left upper lobe of the lung. 
   - The mass is abutting but not directly invading the pleura.
   - According to AJCC staging, a tumor size of 2.3 cm falls under T1 (specifically T1b, which is for tumors >2 cm but ≤3 cm).

2. **Lymph Node Involvement (N):**
   - The report mentions multiple lymph nodes (inferior mediastinal, aortic, and N1) were excised and are negative for tumor involvement.
   - This indicates N0, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, indicating M0.

Based on the above information:
- T1b (tumor size >2 cm but ≤3 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system for lung cancer, a T1b, N0, M0 classification corresponds to Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
13,"## Answer
The pathology report provides the following key information:

1. The primary tumor is a keratinizing squamous cell carcinoma located in the left lung, measuring 2.5 cm in greatest dimension.
2. The tumor involves the left main bronchus but does not invade the pleura, bronchial, or vascular margins.
3. There is no tumor involvement in the peribronchial lymph nodes (0/9), and all other lymph nodes examined (L9, level 7, lymph node in inferior pulmonary vein, level 5) are negative for tumor involvement.
4. The final pathological staging is given as pT2N0.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:
- T2 indicates a tumor size greater than 3 cm but less than or equal to 5 cm, or a tumor that involves the main bronchus without involvement of the carina, or invades visceral pleura, or is associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.
- N0 indicates no regional lymph node metastasis.

Based on the T2N0 classification, the cancer is classified as Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
14,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Pathological T (Tumor size/extent):** T2a
   - T2a indicates a tumor size greater than 3 cm but 5 cm or less, or a tumor that involves the main bronchus without involvement of the carina, or invades visceral pleura, or is associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.

2. **Pathological N (Regional lymph nodes):** N1
   - N1 indicates metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.

3. **Clinical M (Distant metastasis):** M0
   - M0 indicates no distant metastasis.

Based on the TNM classification:
- T2a
- N1
- M0

According to the AJCC 8th edition staging system for lung cancer:
- T2a, N1, M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
15,"## Answer
To determine the AJCC stage of the cancer, we need to consider several factors from the pathology report, including tumor size, lymph node involvement, and metastasis. Let's analyze the provided information:

1. **Tumor Size**: The tumor is 3 x 3 x 3.5 cm. According to AJCC staging for lung cancer, a tumor size of 3 cm or less is typically classified as T1, while a tumor size greater than 3 cm but 5 cm or less is classified as T2.

2. **Lymph Node Involvement**: The report does not specify any lymph node involvement. In AJCC staging, N0 indicates no regional lymph node metastasis.

3. **Distant Metastasis**: There is no mention of distant metastasis in the report. M0 indicates no distant metastasis.

Based on the information provided:
- Tumor size suggests T2 (since it is greater than 3 cm but less than 5 cm).
- No lymph node involvement suggests N0.
- No distant metastasis suggests M0.

Combining these, the TNM classification would be T2N0M0, which corresponds to Stage IIA according to the AJCC 8th edition for lung cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
16,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and metastasis based on the provided pathology report.

1. **Tumor Size and Characteristics**: 
   - The tumor is described as 4.2 x 4.0 x 2.3 cm, which places it in the T2 category (specifically T2a since it is greater than 3 cm but 5 cm or less).
   - The tumor is unifocal and located in the right upper lobe.
   - There is visceral pleural invasion present, which is consistent with T2 classification.

2. **Lymph Node Involvement**:
   - The report states that there is 1 peribronchial lymph node examined and it contains no metastatic carcinoma (0/1). This indicates N0, meaning no regional lymph node metastasis.

3. **Distant Metastasis**:
   - There is no mention of distant metastasis in the report, which implies M0.

4. **pTNM Stage**:
   - The report explicitly states the pTNM stage as pT2a N0, which corresponds to Stage IB according to the AJCC 8th edition staging system for lung cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
17,"## Answer
The pathology report provides the following key information for staging the cancer:

1. **Tumor Size and Characteristics**: The tumor is a 5.0 cm, moderately differentiated squamous cell carcinoma located in the right lower lobe of the lung. It is classified as T2 because it is greater than 3 cm but less than or equal to 5 cm in greatest dimension.

2. **Lymph Node Involvement**: There is metastasis to one of twelve N1 lymph nodes, indicating regional lymph node involvement. The N stage is pN1, which means there is metastasis to ipsilateral peribronchial and/or hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.

3. **Distant Metastasis**: The M stage is pMX, which means distant metastasis cannot be assessed. However, there is no evidence provided in the report of distant metastasis.

Based on the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **Stage I**: T1 or T2a, N0, M0
- **Stage II**: T1 or T2, N1, M0
- **Stage III**: T3 or T4, N0 or N1, M0 or any T, N2, M0
- **Stage IV**: Any T, any N, M1

Given the information:
- The tumor is T2.
- There is N1 lymph node involvement.
- There is no evidence of distant metastasis (M0 is assumed since MX is given).

This corresponds to **Stage II** lung cancer, as it is T2, N1, M0.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
18,"## Answer
The pathology report provides the TNM staging as follows: T2, N0, M0. 

- T2 indicates that the primary tumor is more than 3 cm but not more than 5 cm in greatest dimension, or it has certain features such as invading the visceral pleura or involving the main bronchus without involving the carina.
- N0 indicates that there is no regional lymph node involvement.
- M0 indicates that there is no distant metastasis.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer, a T2, N0, M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
19,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Invasion**: The tumor is 57 mm in greatest dimension and invades the pericardium, but not through to the inner mesothelial-lined surface. There is no pleural invasion on the opposite aspect of the specimen. Vascular, lymphatic, and perineural invasion is present.

2. **Lymph Node Involvement**: The hilar lymph node shows no evidence of metastatic carcinoma, indicating N0 (no regional lymph node metastasis).

3. **Distant Metastasis**: There is no mention of distant metastasis, suggesting M0.

4. **Pathological Stage**: The report explicitly states the pathological stage as T3 N0.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **T3** indicates a tumor greater than 5 cm but less than or equal to 7 cm, or a tumor that invades the chest wall, diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium, or separate tumor nodule(s) in the same lobe as the primary.
- **N0** indicates no regional lymph node metastasis.
- **M0** indicates no distant metastasis.

Based on the T3 N0 M0 classification, the cancer is classified as Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
20,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Invasion**: The primary tumor is a poorly differentiated squamous cell carcinoma, 52 mm in diameter, located in the apical segment of the right lower lobe. It invades the parietal pleura, which classifies it as T3 due to the size and pleural invasion.

2. **Lymph Node Involvement**: There is metastatic carcinoma found in the No. 11 lymph node, indicating regional lymph node involvement. This is classified as N1.

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, so M0 is assumed.

The pathological stage is given as T3 N1 M0. According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **Stage IIIA**: T3 N1 M0

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
21,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is classified as pT3. This indicates that the tumor is larger than 5 cm or has invaded the chest wall, diaphragm, phrenic nerve, mediastinal pleura, or parietal pericardium. In this case, the tumor invades the chest wall and rib, which supports the pT3 classification.

2. **Lymph Nodes (N):** The lymph nodes are classified as pN0, meaning there is no regional lymph node metastasis. All sampled lymph nodes are benign.

3. **Metastasis (M):** There is no mention of distant metastasis in the report, which implies M0.

Based on the AJCC staging system for lung cancer:
- **Stage I** typically involves T1 or T2 tumors with N0 and M0.
- **Stage II** involves T1 or T2 tumors with N1 or T3 tumors with N0, both with M0.
- **Stage III** involves T3 tumors with N1 or T2/T3 tumors with N2, both with M0.
- **Stage IV** involves any T with any N and M1.

Given the classification of pT3, pN0, and M0, the cancer falls into **Stage II** according to the AJCC staging system for lung cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
22,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Characteristics**: The tumor is a moderately differentiated squamous cell carcinoma with a diameter of 5.0 cm. It is not associated with visceral pleural or angiolymphatic invasion.

2. **Lymph Node Involvement**: One of fifteen N1 lymph nodes is positive for metastases, but there is no evidence of metastases in the N2 lymph nodes.

3. **Pathologic Stage**: The report explicitly states the pathologic stage as T2N1MX.

Based on the AJCC (American Joint Committee on Cancer) staging system:

- **T2** indicates a tumor size greater than 3 cm but less than or equal to 5 cm, or a tumor that involves the main bronchus, invades visceral pleura, or is associated with atelectasis or obstructive pneumonitis extending to the hilar region but not involving the entire lung.
  
- **N1** indicates metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.

- **MX** indicates that distant metastasis cannot be assessed.

The combination of T2N1 typically corresponds to Stage II cancer in the AJCC staging system for lung cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
23,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Location**: The primary tumor is a moderately differentiated keratinizing squamous cell carcinoma located in the left lung, measuring 11.0 cm. The tumor is classified as pT2, indicating a tumor size greater than 3 cm but less than or equal to 5 cm, or a tumor that involves the main bronchus, invades visceral pleura, or is associated with atelectasis or obstructive pneumonitis.

2. **Lymph Node Involvement**: The report indicates that there is lymph node involvement, specifically:
   - Level 10 lymph node: 1 out of 1 node is positive for microscopic metastatic carcinoma.
   - Peribronchial lymph nodes: 1 out of 12 nodes is positive for metastatic carcinoma.
   - Other lymph nodes (levels 5, 6, 7, and 9) are negative for tumor involvement.

3. **Pathology Stage**: The pathology stage is given as pT2 N1. The ""N1"" classification indicates that there is metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and/or intrapulmonary nodes, including involvement by direct extension.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:
- **Stage I**: Typically involves T1 or T2 tumors with N0 (no regional lymph node metastasis).
- **Stage II**: Involves T1 or T2 tumors with N1 (metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and/or intrapulmonary nodes).
- **Stage III**: Involves more extensive lymph node involvement (N2 or N3) or larger/more invasive tumors (T3 or T4).
- **Stage IV**: Indicates distant metastasis (M1).

Given the classification of pT2 N1, the cancer is consistent with Stage II, as it involves a T2 tumor with N1 lymph node involvement.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
24,"## Answer
To determine the AJCC stage of the lung cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size**: The tumor size is 3 x 2 x 2 cm. According to AJCC staging for lung cancer, a tumor size of 3 cm falls into the T1 category.

2. **Lymph Node Involvement**: The report indicates that 3 out of 6 lymph nodes are positive for metastasis. This suggests N1 or N2 involvement. Since it specifies ""Intrathoracical,"" it is likely N1, which involves ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T1 (tumor size ≤ 3 cm)
- N1 (metastasis to ipsilateral intrathoracic lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for lung cancer, a T1 N1 M0 corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
25,"## Answer
To determine the AJCC stage of the lung cancer from the pathology report, we need to consider several key factors: tumor size, lymph node involvement, and metastasis.

1. **Tumor Size**: The tumor is 8 x 8 x 8 cm. According to AJCC staging for lung cancer, a tumor larger than 7 cm is classified as T3.

2. **Lymph Node Involvement**: The report indicates that 8 out of 10 intrathoracic lymph nodes are positive for metastasis. This suggests significant lymph node involvement, which corresponds to N2 (metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes).

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on these factors:
- T3 (tumor > 7 cm)
- N2 (metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for lung cancer, a T3 N2 M0 classification corresponds to Stage IIIA.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
26,"## Answer
The provided text does not contain specific information about the tumor size, lymph node involvement, or metastasis, which are critical components for determining the AJCC stage of cancer. The text appears to be instructions for completing a pathology report form rather than an actual pathology report with diagnostic details. Without specific details such as T (tumor size), N (lymph node involvement), and M (metastasis) classifications, it is impossible to accurately determine the cancer stage.

Therefore, the answer is - 
{""stage"" : ""Not Determinable""}"
27,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Characteristics**: The tumor is 7.7 cm in greatest dimension, which places it in the T2 category according to the AJCC staging system. The tumor also invades the visceral pleura, which is consistent with T2 characteristics.

2. **Lymph Node Involvement**: The report states ""pN0: No regional lymph node metastasis,"" indicating that there is no lymph node involvement.

3. **Distant Metastasis**: The report mentions ""pMX: Cannot be assessed,"" which means distant metastasis cannot be evaluated based on the information provided.

Based on the AJCC staging system for lung cancer:
- T2 indicates a tumor greater than 3 cm but less than or equal to 7 cm, or a tumor with certain features such as visceral pleura invasion.
- N0 indicates no regional lymph node metastasis.
- M0 would be assumed in the absence of evidence of distant metastasis, but since pMX is stated, we consider the absence of known metastasis.

Given these factors, the cancer is staged as Stage II, which corresponds to T2 N0 M0.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
28,"## Answer
The pathology report describes a case of squamous cell carcinoma in the left upper lobe of the lung. The tumor measures 2.0 x 2.0 x 1.5 cm and is located 1.8 cm away from the bronchial margin, which is negative for tumor involvement. Importantly, multiple intrapulmonary peribronchial lymph nodes and the visceral pleura are also negative for tumor involvement. Additionally, lymph nodes from various regions (superior mediastinal, aortic, inferior mediastinal, left lower lobe bronchus) are negative for tumor.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer, Stage I is characterized by a tumor that is 4 cm or less in greatest dimension, without involvement of lymph nodes or distant metastasis. In this case, the tumor is 2.0 cm in greatest dimension, and there is no lymph node involvement or distant metastasis reported.

Therefore, based on the information provided in the pathology report, the cancer is consistent with Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
29,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Invasion**: The primary tumor is 4.5 cm in greatest dimension and invades the visceral pleura but not the pericardium. This corresponds to a T2 classification in the TNM staging system.

2. **Lymph Node Involvement**: No tumor is seen in any of the examined lymph nodes (0/7), which corresponds to N0.

3. **Metastasis**: The report indicates pMX, meaning distant metastasis cannot be assessed, but there is no evidence provided of distant metastasis.

Based on the TNM classification:
- T2: Tumor size >3 cm but ≤5 cm or involves the visceral pleura.
- N0: No regional lymph node metastasis.
- M0 (assumed due to lack of evidence of metastasis): No distant metastasis.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:
- T2 N0 M0 corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
30,"## Answer
To determine the AJCC stage of the cancer, we need to consider the primary tumor size and characteristics (T), regional lymph node involvement (N), and distant metastasis (M).

1. **Primary Tumor (T):** 
   - The pathology report describes two lesions in the right upper lobe of the lung. The lesions are 2.6 cm and 4 cm in greatest dimension. 
   - The 2.6 cm lesion has visceral pleural invasion, and the larger lesion extends peripherally but without definite visceral pleural invasion.
   - The report classifies these as pT3 due to the presence of two nodules of similar histology in the same lobe.

2. **Regional Lymph Nodes (N):**
   - The report indicates pN1, which means there is metastatic carcinoma in one of three hilar lymph nodes. 
   - The other lymph nodes (level 11, 2R, 4R, and level 7) are negative for malignancy.

3. **Distant Metastasis (M):**
   - The report states pMX, meaning distant metastasis cannot be assessed.

Based on the AJCC staging system for lung cancer:
- **T3** indicates a tumor that is larger than 5 cm but not larger than 7 cm or has invaded the visceral pleura, or there are separate tumor nodules in the same lobe.
- **N1** indicates metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.
- **M0** would be assumed in the absence of confirmed distant metastasis (pMX).

Combining these, the cancer would be classified as Stage IIIA (T3, N1, M0) according to the AJCC 8th edition staging system for lung cancer.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
31,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis. The provided pathology report includes the following relevant information:

- Tumor size: 3 X 2.5 X 2 cm
- Histologic type: Squamous cell carcinoma
- Tumor extent, lymph nodes, lymphatic invasion, venous invasion, and margins are not specified.
- There is no mention of metastasis or additional tumor nodules.

Based on the tumor size alone (3 cm in the largest dimension), and without any information on lymph node involvement or distant metastasis, we can make an assumption:

- For lung cancer, a tumor size of 3 cm or less without lymph node involvement or metastasis typically corresponds to Stage I.

Since there is no information provided about lymph node involvement or metastasis, we assume there is none, which supports the classification as Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
32,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Characteristics**: The tumor is described as an invasive poorly differentiated squamous cell carcinoma with a greatest dimension of 4.0 cm. There is no pleural invasion, and the bronchial resection margin is negative for the tumor. Venous invasion is present.

2. **Lymph Node Involvement**: One lobar lymph node out of nine is positive for metastatic adenocarcinoma, indicating pN1 status. This means there is metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes.

3. **Metastasis**: The report states pMX, meaning distant metastasis cannot be assessed.

4. **Pathologic Staging**: The report explicitly states the pathologic staging as pT2N1. According to the AJCC staging system, pT2 indicates a tumor greater than 3 cm but less than or equal to 5 cm, or a tumor with certain other features, and pN1 indicates regional lymph node involvement.

Based on the AJCC staging system for lung cancer:
- **Stage I**: Typically involves T1 or T2a tumors with no lymph node involvement (N0).
- **Stage II**: Typically involves T2b or T3 tumors with N0 or T1/T2 tumors with N1 lymph node involvement.
- **Stage III**: Typically involves T1-T3 tumors with N2 or T3/T4 tumors with N1/N2 lymph node involvement.
- **Stage IV**: Involves any T, any N with M1 (distant metastasis).

Given the information:
- The tumor is pT2 (size >3 cm but ≤5 cm).
- There is N1 lymph node involvement.
- Distant metastasis cannot be assessed (pMX).

Therefore, the cancer is classified as Stage II according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
33,"## Answer
The pathology report provides the following key information for staging the cancer according to the AJCC (American Joint Committee on Cancer) guidelines:

1. **Primary Tumor (pT):** The tumor is classified as pT2a. This indicates that the tumor is greater than 3 cm but less than 5 cm in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion in the main bronchus. There is no visceral pleura invasion or tumor extension identified.

2. **Regional Lymph Nodes (pN):** The classification is pN0, meaning there is no regional lymph node metastasis. All examined lymph nodes are negative for malignancy.

3. **Distant Metastasis (pM):** Not applicable, which typically implies no evidence of distant metastasis.

Based on the AJCC staging system for lung cancer:
- **Stage I** is characterized by a tumor that is limited in size and has not spread to lymph nodes or distant sites. Specifically, Stage I includes T1 or T2a tumors with N0 and M0.
- **Stage II** involves larger tumors or those with limited lymph node involvement.
- **Stage III** involves more extensive lymph node involvement or larger tumors with local invasion.
- **Stage IV** involves distant metastasis.

Given the tumor size (pT2a), lack of lymph node involvement (pN0), and no distant metastasis, the cancer is consistent with **Stage I**.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
34,"## Answer
The pathology report provides the following key information:

1. **Primary Tumor (pT):** The tumor measures 5.5 cm and extends through the pleura but is not identified at the outer surface of the specimen. This suggests a T2 or T3 classification, depending on the specific criteria for pleural involvement.

2. **Regional Lymph Nodes (pN):** pN0, indicating no regional lymph node metastasis.

3. **Distant Metastasis (pM):** pMx, meaning distant metastasis cannot be assessed.

Given these details, the tumor is larger than 5 cm and involves the pleura, which typically corresponds to a T2b or T3 classification. However, there is no lymph node involvement (N0) and no confirmed distant metastasis (Mx).

According to the AJCC staging system for lung cancer:
- **Stage I** is typically T1 or T2a, N0, M0.
- **Stage II** can be T2b or T3, N0, M0.
- **Stage III** involves N1 or N2 lymph node involvement.
- **Stage IV** involves distant metastasis (M1).

Since the tumor is T2b or T3, N0, Mx, it aligns with Stage II, as there is no lymph node involvement or confirmed distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
35,"## Answer
The pathology report provides the following key information for staging the cancer:

1. **Tumor Size and Invasion**: The tumor is described as a poorly differentiated squamous cell carcinoma measuring 4.9 x 4.7 x 4.5 cm. It invades through the visceral and parietal pleura into the chest wall skeletal muscle and into rib bone. This indicates a T3 classification due to the size and local invasion into the chest wall.

2. **Lymph Node Involvement**: All lymph nodes examined (R4, Level 7, L4, R2, Level 10, Level 11) are negative for malignancy, indicating N0 classification.

3. **Metastasis**: There is no mention of distant metastasis, which would be classified as M0.

4. **Pleural Invasion**: The report mentions carcinoma invading through the visceral and parietal pleura, classified as PL3.

Based on the TNM classification provided in the report (pT3 pN0 PL3), the cancer is staged according to the AJCC guidelines. T3N0M0 typically corresponds to Stage IIB, but the presence of PL3 (invasion through the pleura) can influence staging.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
36,"## Answer
To determine the AJCC stage of the lung cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size and Local Invasion (T):** 
   - The tumor is described as a 4.5 x 4 x 3 cm mass. 
   - It extends to within a few millimeters of the bronchial margin and involves extensive in situ carcinoma, but does not invade the pleura.
   - This suggests a T2 classification, as it is more than 3 cm but less than 5 cm and does not invade the visceral pleura or main bronchus.

2. **Lymph Node Involvement (N):**
   - Multiple intrapulmonary peribronchial lymph nodes (6 of 14) are involved.
   - Metastasis is also present in aortopulmonary (2 of 2) and anterior mediastinal (1 of 2) lymph nodes.
   - This indicates N2 classification, as there is involvement of ipsilateral mediastinal and/or subcarinal lymph nodes.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, so M0 is assumed.

Based on the TNM classification:
- T2 (tumor size and local invasion)
- N2 (lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for lung cancer, a T2, N2, M0 classification corresponds to Stage IIIA.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
37,"## Answer
The pathology report describes a poorly differentiated large cell carcinoma with squamoid features in the right lower lobe of the lung. The tumor is 3.5 cm in greatest dimension and shows pulmonary parenchymal invasion. Importantly, the closest inked pleural margin is negative for malignancy, and there is no lymphovascular invasion. Additionally, all lymph nodes examined (anterior lobular, subcarinal, right hilum, right lower peritracheal) are benign, indicating no lymph node involvement. There is no mention of distant metastasis.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:
- Stage I is characterized by a tumor that is 4 cm or less in greatest dimension, with no lymph node involvement and no distant metastasis.
- Stage II involves a larger tumor or local spread to nearby structures or lymph nodes.
- Stage III involves more extensive local spread or lymph node involvement.
- Stage IV involves distant metastasis.

Given that the tumor is 3.5 cm, there is no lymph node involvement, and no distant metastasis is reported, the cancer fits the criteria for Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
38,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Location**: The tumor is located in the right lower lobe of the lung and measures 2.9 x 2.5 x 1.8 cm. It is described as moderately to poorly differentiated squamous cell carcinoma. The tumor extends subpleurally but not to the pleural surface, and there is no vascular or perineural invasion. The bronchial margin is free of tumor.

2. **Lymph Node Involvement**: Multiple lymph nodes were examined, including level VII mediastinal and right mediastinal lymph nodes level XI. All lymph nodes examined were benign, with no metastatic involvement (0/1, 0/1, 0/3).

3. **Distant Metastasis**: There is no mention of distant metastasis in the report.

Based on the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **T (Tumor size and extent)**: The tumor is less than 3 cm and does not invade the main bronchus or visceral pleura, which corresponds to T1.
- **N (Regional lymph nodes)**: No regional lymph node metastasis is found, corresponding to N0.
- **M (Distant metastasis)**: No distant metastasis is mentioned, corresponding to M0.

Combining these, the cancer is classified as T1N0M0, which corresponds to Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
39,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Extent (T):** The tumor is described as being up to 8.5 cm in size, located in the right lower lobe, and extending up to the pleura. However, there is no unequivocal infiltration of the visceral pleura. The TNM classification given is pT2.

2. **Lymph Node Involvement (N):** The report states pN0, indicating no regional lymph node metastasis. All lymph nodes identified and excised are tumor-free.

3. **Metastasis (M):** The report states pMX, meaning distant metastasis cannot be assessed. However, there is no mention of distant metastasis being present.

4. **Resection Margins:** The resection margin of the bronchus and vessels are tumor-free, indicating R0 resection (no residual tumor).

5. **Stage Provided in Report:** The report explicitly states ""stage IB.""

Based on the TNM classification provided (pT2 pN0 pMX) and the explicit stage mentioned in the report (stage IB), the cancer is classified as Stage I according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
40,"## Answer
The pathology report provides detailed information about the tumor and lymph nodes:

1. **Primary Tumor (pT):** The tumor is classified as pT3. This is due to the presence of separate tumor nodules in the same lobe, away from the main central tumor. According to the AJCC staging system, pT3 indicates a tumor greater than 7 cm in greatest dimension, or a tumor of any size with separate tumor nodules in the same lobe.

2. **Regional Lymph Nodes (pN):** The report states pN0, meaning there is no regional lymph node metastasis. All examined lymph nodes (8 in total) are negative for metastatic carcinoma.

3. **Distant Metastasis (pM):** The report does not mention any distant metastasis, which implies pM0.

Based on the TNM classification:
- **T3**: Tumor with separate nodules in the same lobe.
- **N0**: No regional lymph node involvement.
- **M0**: No distant metastasis.

According to the AJCC staging system for lung cancer, a combination of T3, N0, and M0 corresponds to Stage IIB. However, the options provided do not include Stage IIB. The closest option that fits the description of a T3 tumor without lymph node involvement or distant metastasis is Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
41,"## Answer
To determine the AJCC stage of the lung cancer from the pathology report, we need to consider several key factors:

1. **Tumor Size**: The tumor size is 6.5 x 5.5 x 5.5 cm. According to the AJCC 8th edition for lung cancer, a tumor size greater than 5 cm but less than or equal to 7 cm is classified as T2b.

2. **Lymph Node Involvement**: The report states that 0 out of 6 lymph nodes are positive for metastasis, indicating N0 (no regional lymph node metastasis).

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on these factors:
- T2b (tumor size > 5 cm but ≤ 7 cm)
- N0 (no regional lymph node metastasis)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging for lung cancer, a T2b N0 M0 classification corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
42,"## Answer
The pathology report indicates the presence of squamous cell carcinoma in multiple soft tissue locations, including the serratus muscle, second rib, intercostal muscle, middle scalene muscle, and the lung's left upper lobe. The tumor in the lung measures 4.5 cm and invades deep into the chest wall. The report specifies a pathological stage of pT3, N0, Mx.

- **T3** indicates a tumor that is more than 7 cm or one that invades the chest wall, diaphragm, phrenic nerve, mediastinal pleura, or parietal pericardium, or separate tumor nodules in the same lobe.
- **N0** indicates no regional lymph node metastasis.
- **Mx** indicates that distant metastasis cannot be assessed.

According to the AJCC staging system for lung cancer:
- **Stage IIIA** can include T3, N0, M0.
- **Stage IIIB** and **Stage IIIC** involve more advanced nodal involvement (N1, N2, or N3).
- **Stage IV** involves distant metastasis (M1).

Given the information provided (pT3, N0, Mx), the cancer is classified as Stage IIIA, as there is no evidence of nodal involvement or distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
43,"## Answer
The pathology report provides the following key information:

1. **Tumor Type**: Squamous cell carcinoma.
2. **Tumor Size**: 2x2x1.8 cm.
3. **Lymph Node Involvement**: Two peribronchial lymph nodes are negative for tumor (0/2).
4. **Margins**: Bronchial and visceral pleural margins are negative for tumor.
5. **Pathologic Stage**: pT1N0.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **T1** indicates a tumor that is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, and without bronchoscopic evidence of invasion more proximal than the lobar bronchus.
- **N0** indicates no regional lymph node metastasis.

Given the information:
- The tumor is 2 cm in size, which fits the T1 category.
- There is no lymph node involvement (N0).

Therefore, the pathologic stage pT1N0 corresponds to Stage I lung cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
44,"## Answer
To determine the AJCC stage of the lung cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates a 3.5 cm invasive, poorly differentiated squamous cell carcinoma in the left lower lobe of the lung. According to AJCC staging for lung cancer, a tumor size of more than 3 cm but 5 cm or less is classified as T2.

2. **Lymph Node Involvement (N):** The report states that the level 9L lymph node is negative for metastatic carcinoma (0/1). This means there is no regional lymph node involvement, which corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the TNM classification:
- T2 (tumor size >3 cm but ≤5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

The combination of T2, N0, M0 corresponds to Stage I lung cancer according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
45,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Location**: The tumor is a 9.5 cm moderately differentiated squamous cell carcinoma located in the left upper lobe of the lung with paraphrenic extension. This size and extension classify it as T3.

2. **Lymph Node Involvement**: All sampled lymph nodes are benign, indicating no regional lymph node metastasis. This is classified as N0.

3. **Distant Metastasis**: The report states ""Mx,"" meaning that the presence of distant metastasis cannot be assessed from the information provided.

4. **Pathologic Stage**: The report explicitly states the pathologic stage as pT3N0Mx.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **Stage III** includes T3N0M0, T3N1M0, T3N2M0, etc., where the tumor is larger than 7 cm or has invaded certain structures, but there is no distant metastasis (M0).

- **Stage IV** would require evidence of distant metastasis (M1), which is not confirmed in this report.

Given the information, the tumor is classified as T3N0Mx, which aligns with Stage III when considering the T3 classification and absence of lymph node involvement (N0), despite the Mx status.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
46,"## Answer
To determine the AJCC stage of the lung cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report states that the squamous cell carcinoma in the right lung has a greatest diameter of 5.0 cm. According to AJCC staging, a tumor size of more than 4 cm but less than or equal to 5 cm is classified as T2b.

2. **Lymph Node Involvement (N):** The report indicates metastatic carcinoma in regional lymph nodes, with 6 out of 9 peribronchial lymph nodes and 1 out of 1 parenchymal lymph node showing metastasis. This suggests significant regional lymph node involvement. According to AJCC staging, involvement of ipsilateral peribronchial and/or hilar lymph nodes is classified as N1. However, the report also mentions direct tumor extension into lymph nodes, which could suggest more extensive involvement, potentially N2 if mediastinal nodes are involved.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report. The pericardium biopsy was benign, and no tumor was seen in the pericardium or other distant sites. Therefore, M0 is assumed.

Based on the above information:
- T2b (tumor size 5.0 cm)
- N1 or possibly N2 (regional lymph node involvement)
- M0 (no distant metastasis)

Given the lymph node involvement and the absence of distant metastasis, the cancer is likely at least Stage III. Stage III is characterized by larger tumors and/or more extensive lymph node involvement without distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
47,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Extent (T):** The tumor is described as a large-cell squamous cell carcinoma, poorly differentiated, with a maximum size of 9 cm. It extends to the pleura but does not infiltrate the visceral pleura. The TNM classification given is pT2, which typically indicates a tumor size greater than 3 cm but less than or equal to 5 cm, or a tumor that involves the main bronchus, visceral pleura, or causes atelectasis or obstructive pneumonitis.

2. **Lymph Node Involvement (N):** The report states pN0, indicating no regional lymph node metastasis. The lymph nodes examined (stations 4 to 11) are tumor-free.

3. **Distant Metastasis (M):** The report indicates pMX, meaning distant metastasis cannot be assessed. However, there is no evidence provided in the report of distant metastasis.

4. **Other Considerations:** The report mentions RX, indicating that the resection margins are uncertain, but the bronchus resection margin is tumor-free. The tumor extends to the visceral pleura but does not infiltrate it.

Based on the TNM classification provided (pT2 pN0 pMX), the cancer is classified as Stage IB according to the AJCC staging system for lung cancer. Stage IB typically corresponds to T2a N0 M0, where the tumor is larger than 3 cm but 5 cm or less, without lymph node involvement or distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
48,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Type and Size**: The tumor is a squamous cell carcinoma measuring 1.8 cm.
2. **Histologic Grade**: Poorly differentiated.
3. **Surgical Margins**: All surgical margins are free of tumor.
4. **Direct Extension of Tumor**: Not identified.
5. **Lymphatic and Venous Invasion**: Both are absent.
6. **Lymph Nodes**: 6 lymph nodes were examined, and none were involved (0/6).
7. **TNM Staging**: pT1a, pN0, pMX.

Based on the TNM staging:
- **T1a** indicates a tumor size of 2 cm or less.
- **N0** indicates no regional lymph node metastasis.
- **MX** indicates that distant metastasis cannot be assessed.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:
- A tumor classified as T1a, N0, M0 corresponds to Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
49,"## Answer
The pathology report indicates the following key findings:

1. The cancer is a poorly differentiated non-small cell carcinoma of the lung with both squamous and high-grade spindle cell features.
2. The carcinoma involves the pleural surface, which suggests potential local extension.
3. All surgical margins of resection are negative for tumor, indicating no residual tumor at the resection margins.
4. One hilar lymph node and associated fibroadipose tissue are negative for tumor.
5. Lymph nodes at station 5 and L11 are also negative for tumor.

Based on the AJCC staging system for lung cancer:

- The involvement of the pleural surface suggests at least a T2 classification, as T2 includes tumors that invade the visceral pleura.
- The absence of lymph node involvement (N0) and no distant metastasis (M0) are indicated by the negative lymph nodes and lack of mention of distant spread.

Given these findings, the cancer is likely to be classified as Stage II, as Stage I would typically not involve the pleural surface, and Stage III or IV would involve lymph node metastasis or distant spread, respectively.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
50,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Location**: The tumor is 37 mm in maximal dimension, located in the left upper lobe of the lung. It is at least 25 mm deep to the closest pleural surface and 30 mm from the bronchial resection margin.

2. **Histological Findings**: The tumor is a very poorly-differentiated squamous cell carcinoma. There is no pleural invasion, blood vessel invasion, lymphatic permeation, or perineural permeation identified.

3. **Lymph Node Involvement**: No lymph node metastases are present. The peribronchial lymph nodes show sinus histiocytosis and carbon pigment but no evidence of tumor.

4. **Pathological Stage**: The report states the pathological stage as T2N0Mx.

- **T2** indicates a tumor size greater than 3 cm but 5 cm or less, or a tumor that involves the main bronchus without involvement of the carina, invades visceral pleura, or is associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.
- **N0** indicates no regional lymph node metastasis.
- **Mx** indicates that distant metastasis cannot be assessed.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **Stage I** includes T1 or T2 tumors with N0 and M0.
- **Stage II** includes T2 tumors with N1 or T3 tumors with N0, both with M0.
- **Stage III** includes T1-T3 tumors with N2 or T4 tumors with N0-N2, both with M0.
- **Stage IV** includes any T, any N, and M1.

Given the information, the tumor is classified as T2N0Mx, which corresponds to Stage I when considering the absence of lymph node involvement (N0) and no evidence of distant metastasis (Mx, but typically assumed M0 for staging purposes unless otherwise specified).

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
51,"## Answer
To determine the AJCC stage of lung cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis. The provided pathology report includes the following details:

- Tumor size: 4 x 3 x 3.5 cm
- Histologic type: Squamous cell carcinoma
- Other critical factors such as lymph node involvement, distant metastasis, and tumor extent are not specified.

Based on the AJCC 8th edition staging system for lung cancer:
- Tumor size of 4 cm falls into the T2 category (T2a if >3 cm but ≤4 cm).
- Without information on lymph node involvement (N) or distant metastasis (M), we cannot definitively assign a stage beyond T2a.

In the absence of lymph node involvement or metastasis, a T2a tumor would typically be classified as Stage IB. However, due to the lack of specific information on lymph nodes and metastasis, we must assume the least advanced stage that fits the given data.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
52,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Location**: The primary tumor is a poorly differentiated squamous cell carcinoma measuring 28 mm in maximal dimension, located in the right upper lobe. This corresponds to a T2 classification, as the tumor is greater than 3 cm but less than 5 cm in greatest dimension.

2. **Lymph Node Involvement**: The report mentions that the tumor appears to directly invade a peribronchial lymph node, which indicates N1 classification. However, other lymph nodes (right middle lobe, right upper lobe, No. 7, No. 8, No. 9, azygous, and right main bronchus) show reactive changes only, with no evidence of malignancy, except for one lymph node presumed to have a deposit of squamous cell carcinoma.

3. **Metastasis**: The report does not provide evidence of distant metastasis, hence MX (distant metastasis cannot be assessed).

4. **Additional Findings**: There is probable pleural invasion, but no blood vessel, lymphatic, or perineural invasion is noted. The tumor extends closely to the diathermied resection margin, but the invasive component is clear.

Based on the AJCC staging system:
- **T2**: Tumor size greater than 3 cm but less than 5 cm.
- **N1**: Metastasis to ipsilateral peribronchial and/or hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension.
- **MX**: Distant metastasis cannot be assessed.

The combination of T2N1MX corresponds to Stage II cancer according to the AJCC staging system for lung cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
53,"## Answer
The pathology report provides the following key information for staging the lung cancer according to the AJCC (American Joint Committee on Cancer) guidelines:

1. **Tumor Size and Extent (T):** The tumor is described as a 4 cm invasive squamous cell carcinoma located in the right lower lobe of the lung. The tumor does not involve the visceral pleura, and there is no lymphovascular space invasion. The tumor size of 4 cm classifies it as T2 (since T1 is for tumors ≤3 cm).

2. **Regional Lymph Nodes (N):** The report indicates that there is no evidence of metastatic carcinoma in any of the examined lymph nodes (0/1 in level 9, 0/4 in level 11, 0/11 in peribronchial, 0/1 in level 4, and no metastasis in level 7 nodes). This classifies the nodal involvement as N0.

3. **Distant Metastasis (M):** The report states ""Mx,"" indicating that the presence of distant metastasis cannot be assessed from the information provided.

Based on the TNM classification:
- T2: Tumor size >3 cm but ≤5 cm.
- N0: No regional lymph node metastasis.
- Mx: Distant metastasis cannot be assessed.

According to the AJCC staging system for lung cancer, a T2N0Mx classification corresponds to Stage I cancer, specifically Stage IB, since Stage IA would require a T1 classification.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
54,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is 5.6 cm in greatest dimension and involves the main bronchus but does not extend into the pleura. This is classified as pT2b.

2. **Regional Lymph Nodes (N):** All examined lymph nodes are negative for malignancy, which is classified as pN0.

3. **Distant Metastasis (M):** Distant metastasis is not evaluated (pMX), but since there is no evidence of distant metastasis provided, we assume M0 for staging purposes.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **Stage I:** T1 or T2a, N0, M0
- **Stage II:** T2b, N0, M0 or T1-T2a, N1, M0
- **Stage III:** T1-T2b, N2, M0 or T3, any N, M0
- **Stage IV:** Any T, any N, M1

Given the information:
- The tumor is T2b.
- There is no lymph node involvement (N0).
- There is no evidence of distant metastasis (assumed M0).

This corresponds to **Stage II** lung cancer, as T2b, N0, M0 fits the criteria for Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
55,"## Answer
The pathology report provides the following key information for staging:

1. **T Stage (Tumor size and extent):** The tumor is described as ""invasive moderately differentiated squamous cell carcinoma"" with a size of 4.5 cm. The pathologic T stage is given as pT2a. According to the AJCC 7th Edition, T2a indicates a tumor size greater than 3 cm but 5 cm or less, or a tumor that invades the visceral pleura or involves the main bronchus without involvement of the carina.

2. **N Stage (Regional lymph nodes):** The report states ""N1 lymph nodes: Number of N1 lymph nodes positive: 0"" and ""N2 lymph nodes: Number of N2 lymph nodes positive: 0."" The pathologic N stage is given as pN0, indicating no regional lymph node metastasis.

3. **M Stage (Distant metastasis):** The report states ""M Stage, Pathologic: Not applicable,"" which implies there is no evidence of distant metastasis (M0).

Based on the TNM classification:
- T2a
- N0
- M0

According to the AJCC 7th Edition staging system for lung cancer, a combination of T2a, N0, and M0 corresponds to Stage IB.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
56,"## Answer
The pathology report provides the following key information:

1. **Tumor Type and Grade**: The tumor is a squamous cell carcinoma, moderately differentiated (G2).

2. **Tumor Size and Location**: The largest tumor mass is 3.0 x 3.0 x 3.0 cm, located in the right lower lobe of the lung.

3. **Tumor Extension and Invasion**: There is no visceral pleural invasion identified, and the tumor appears confined to the lung. There are findings suspicious for lymphovascular invasion, but not confirmed.

4. **Lymph Node Status**: Two lymph nodes were examined, and neither contained metastatic carcinoma (0/2).

5. **pTN Stage**: Initially classified as pT1bN0, but revised to pT3N0 due to the presence of a satellite tumor.

6. **Revised Classification**: The presence of a satellite tumor classifies the neoplasm as T3, which is crucial for staging.

According to the AJCC (American Joint Committee on Cancer) staging system for lung cancer:

- **Stage I**: Typically involves T1 or T2 tumors with N0 (no regional lymph node metastasis).
- **Stage II**: Involves T1 or T2 tumors with N1 (metastasis to nearby lymph nodes) or T3 with N0.
- **Stage III**: Involves T3 with N1 or any T4 tumor, or N2 (metastasis to more distant lymph nodes).
- **Stage IV**: Involves any T with M1 (distant metastasis).

Given the revised classification of pT3N0, the tumor is classified as Stage II according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
